Skip to content

Application of Photon-counting CT in Head and Neck Vascular Diseases

Research on the Application of Photon-Counting CT in Head and Neck Vascular Diseases

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121453
Enrollment
Unknown
Registered
2026-03-31
Start date
2026-01-03
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck vascular diseases include vascular stenosis, aneurysms, vascular malformations, moyamoya disease, and vasculitis, among others.

Interventions

Experimental Group:Photon technology CT scan
control Group:Simulate routine CTA check

Sponsors

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18–80 years, and clinically suspected of having head and neck vascular diseases on initial diagnosis; 2.Voluntarily undergo photon-counting CT examination and provide informed consent to participate in this study; 3.Be able to cooperate with the completion of the examination and subsequent follow-up, with complete clinical and imaging data available for collection; 4.Renal function indicators (serum creatinine, blood urea nitrogen) within the normal range or showing mild abnormalities;

Exclusion criteria

Exclusion criteria: 1.Patients with a history of hypersensitivity to iodinated contrast media; 2.Patients with severe hepatorenal insufficiency, coagulation dysfunction, or severe cardio-cerebrovascular diseases (e.g., acute myocardial infarction, acute phase of cerebral hemorrhage); 3.Pregnant or lactating women;

Design outcomes

Primary

MeasureTime frame
Diagnostic Accuracy;

Countries

China

Contacts

Public ContactShanshan Lu

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

lushan1118@163.com+86 25 6813 6988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026